Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas

Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas

Vestibular schwannoma (VS) is the most common tumor of the cerebellopontine angle, and it typically presents with sensorineural hearing loss. The genomic landscape of schwannoma is complex and many of the molecules implicated in VS pathogenesis represent targets not amenable to antibody-based or sma...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Sagers, Jessica E., Landegger, Lukas D., Stankovic, Konstantina M., Ren, Yin, Bhatia, Sangeeta N
Kolejni autorzy:	Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format:	Artykuł
Wydane:	Nature Publishing Group 2018
Dostęp online:	http://hdl.handle.net/1721.1/115218 https://orcid.org/0000-0002-1293-2097

Podobne zapisy

Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage
od: Dilwali, Sonam, i wsp.
Wydane: (2016)

iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
od: Lo, Justin H., i wsp.
Wydane: (2020)

Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4
od: Ren, Yin, i wsp.
Wydane: (2014)

From bench to bedside : elucidating vestibular schwannoma pathobiology to devise effective pharmacotherapies
od: Dilwali, Sonam
Wydane: (2015)

Identification and characterization of receptor-specific peptides for siRNA delivery
od: Ren, Yin, i wsp.
Wydane: (2012)

Cell-penetrating peptides as drug delivery system for SiRNA.
od: Meriska Sudarmadji.
Wydane: (2012)

Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival bearing tumors derived from Brca1-deficient ovarian cancer cells
od: Goldberg, Michael Solomon, i wsp.
Wydane: (2011)

Reticular and microcystic schwannoma: a distinctive tumor of the gastrointestinal tract.
od: Chetty, R
Wydane: (2011)

Functional Delivery of siRNA in Mice Using Dendriworms
od: Agrawal, Amit, i wsp.
Wydane: (2011)

Schwannoma of the ganglion geniculi
od: Hahn, U, i wsp.
Wydane: (2003)

[Schwannoma of the geniculate ganglion]
od: Hahn, U, i wsp.
Wydane: (2003)

Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
od: Ezzat, K, i wsp.
Wydane: (2012)

Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles
od: Alabi, Christopher A., i wsp.
Wydane: (2014)

A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors
od: Hauert, Sabine, i wsp.
Wydane: (2015)

FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA-Nanocomplexes
od: Alabi, Christopher A., i wsp.
Wydane: (2013)

Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.
od: Kooijmans, SA, i wsp.
Wydane: (2013)

Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
od: Goldberg, Michael Solomon, i wsp.
Wydane: (2012)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
od: Gilles, Maud-Emmanuelle, i wsp.
Wydane: (2020)

Quantum dots-siRNA nanoplexes for gene silencing in central nervous system tumor cells
od: Lin, Guimiao, i wsp.
Wydane: (2018)

The future of TNF-α antagonism
od: Taylor, P
Wydane: (2007)

Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain
od: Joo, Jinmyoung, i wsp.
Wydane: (2021)

Psammomatous melanotic schwannoma presenting as colonic polyps.
od: Chetty, R, i wsp.
Wydane: (2007)

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
od: Xu, Xiaoyang, i wsp.
Wydane: (2014)

Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis
od: Zha, L, i wsp.
Wydane: (2017)

Substrate architecture effect on siRNA silencing.
od: Koh, Hwee Ciah.
Wydane: (2009)

Lipid-Based Formulations for siRNA Delivery
od: Foged, C, i wsp.
Wydane: (2009)

Polymeric carrier systems for siRNA delivery.
od: Vader, P, i wsp.
Wydane: (2012)

Raw data for siRNA loaded nanodroplets
od: Stride, E
Wydane: (2017)

The effects of tumor necrosis factor (TNF) derivatives on TNF receptors.
od: Tchorzewski, H, i wsp.
Wydane: (1993)

Ultrasensitive tumour-penetrating nanosensors of protease activity
od: Kwon, Ester J, i wsp.
Wydane: (2021)

Rare extraconal orbital mass: A benign schwannoma
od: Azida Juana, W.A.K., i wsp.
Wydane: (2016)

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis.
od: Clark, K, i wsp.
Wydane: (2013)

Tumor-penetrating delivery of small interfering RNA therapeutics
od: Ren, Yin, Ph. D. Massachusetts Institute of Technology
Wydane: (2012)

Degradable Polyelectrolyte Multilayers that Promote the Release of siRNA
od: Flessner, Ryan M., i wsp.
Wydane: (2012)

Nanolayered siRNA Dressing for Sustained Localized Knockdown
od: Wang, Mary, i wsp.
Wydane: (2014)

Exosome-mediated delivery of siRNA in vitro and in vivo.
od: El-Andaloussi, S, i wsp.
Wydane: (2012)

Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
od: Castillo, Betzaida, i wsp.
Wydane: (2013)

Alkane-modified short polyethyleneimine for siRNA delivery
od: Anderson, Daniel, i wsp.
Wydane: (2017)

Ribozymes and siRNA for the treatment of diseases of the nervous system.
od: Wood, M, i wsp.
Wydane: (2003)

Quantification of siRNA using competitive qPCR.
od: Liu, W, i wsp.
Wydane: (2009)